Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 22, Issue 12, Pages 630-635Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S0165-6147(00)01866-6
Keywords
-
Categories
Ask authors/readers for more resources
Effective pharmacological treatment of cognitive disorders in dementia is lacking despite extensive efforts to produce active therapy aimed at neuronal and vascular targets. In this review, the evidence for the involvement of vascular mechanisms in the pathology and evolution of dementia will be examined and the potential importance of age-related changes in cerebrovascular structure and cerebral blood flow (CBF) autoregulation will be discussed. With a description of recent clinical results (on statins, angiotensin-converting enzyme inhibitors and Ca2+ channel blockers) and experimental results (on beta -amyloid), the impact of drugs on cerebrovascular targets is examined. The working hypothesis that targeting vascular mechanisms in dementia is an option for future therapy is proposed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available